The Mirkin Group
Chad Mirkin
Dr. Chad A. Mirkin is the Director of the International Institute for Nanotechnology and the George B. Rathmann Professor of Chemistry, Chemical and Biological Engineering, Biomedical Engineering, Materials Science & Engineering, and Medicine at Northwestern University. He is a chemist and a world-renowned nanoscience expert, who is known for his discovery and development of spherical nucleic acids (SNAs) and SNA-based biodetection and therapeutic schemes, dip-pen nanolithography (DPN) and related cantilever-free nanopatterning and materials discovery methodologies, and high-area rapid printing (HARP), and contributions to supramolecular chemistry and nanoparticle synthesis. He has authored over 930 manuscripts and over 1,420 patent applications worldwide (over 450 issued) and founded multiple companies, including Nanosphere, TERA-print, Azul 3D, Flashpoint Therapeutics, and Mattiq.